Bill > SB0332

This bill establishes a cap on insulin prescription drug costs for health insurance plans in Indiana. Specifically, for health insurance plans issued or renewed after June 30, 2025, insurers must limit an insured person's out-of-pocket expenses for a 30-day supply of prescription insulin drugs to no more than $35, regardless of the number or types of insulin prescriptions. The bill defines "prescription insulin drug" as a prescription medication containing insulin that is used to treat diabetes and medically necessary. Insurers are permitted to set the cost-sharing amount lower than the $35 cap if they choose. The bill also includes a provision that exempts health insurance plans from the cap if applying the $35 limit would cause the plan to lose its status as a high-deductible health plan under federal tax code. This legislation aims to make insulin more affordable for people with diabetes by reducing the financial burden of medication costs.

Health and Social Services

https://iga.in.gov/legislative/2025/bills/senate/332/details